Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Veziris

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Microorganisms|June 24, 2022
Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from FranceIsabelle Bonnet, Elie Haddad, Lorenzo Guglielmetti, et al.
Nature Communications|October 22, 2025
The role of cytochrome bc<sub>1</sub> inhibitors in future tuberculosis treatment regimensClara Aguilar-Pérez, Anne J Lenaerts, Cristina Villellas, et al.
Nature Communications|April 7, 2026
Alpibectir-Ethionamide combination (AlpE) for the treatment of tuberculosisZainab Edoo, Camille Grosse, Thomas Maitre, et al.
Lancet (London, England)|September 15, 2018
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis, Nafees Ahmad, Shama D Ahuja, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Microorganisms|June 24, 2022
Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from FranceIsabelle Bonnet, Elie Haddad, Lorenzo Guglielmetti, et al.
Nature Communications|October 22, 2025
The role of cytochrome bc<sub>1</sub> inhibitors in future tuberculosis treatment regimensClara Aguilar-Pérez, Anne J Lenaerts, Cristina Villellas, et al.
Nature Communications|April 7, 2026
Alpibectir-Ethionamide combination (AlpE) for the treatment of tuberculosisZainab Edoo, Camille Grosse, Thomas Maitre, et al.
Lancet (London, England)|September 15, 2018
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis, Nafees Ahmad, Shama D Ahuja, et al.
Pageof 12